Interest in Electronic Applications for Patients With Glaucoma

Glaucoma Clinical Trial

— GlaucomaApp  

Official title:

Interest of Patients and Their Caregivers in A Smartphone- and Tablet-Based Application for Patients With Glaucoma

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02659709
• Other study ID #: 14-413E
• Status: Completed
• Start date: June 2015
• Est. completion date: October 2016

Study information

• Verified date: June 2019
• Source: Wills Eye
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To evaluation interest in use of smartphone- and tablet-based application (app) for participants with glaucoma, ocular hypertension, those at risk and their caregivers.

Description:

This study is designed to determine the amount of interest in an educational application (app) on social media for glaucoma patients and their caregivers.

The purpose of this App is to enhance understanding of glaucoma by using short video tutorials. The App will include glaucoma eye drop medication reminders, a short video tutorial which aims to improve understanding of how visual field testing should be performed, how to administer eye drops and a feature that will enable participants to store and organize testing results using a mobile device.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: October 2016
• Est. primary completion date: October 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Anyone affected by glaucoma

• Family and friends of someone with glaucoma

Exclusion Criteria:

• unable to complete survey

Related Conditions & MeSH terms

• Glaucoma

Intervention

Device:
• Interest in medical education through social media
Measuring interest in social media technology designed to educate glaucoma patients about disease, testing, and treatments with reminders for taking medications.

Locations

Country	Name	City	State
United States	Wills Eye Hospital	Philadelphia	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
Wills Eye

Country where clinical trial is conducted

United States, 

References & Publications (1)

Waisbourd M, Dhami H, Zhou C, Hsieh M, Abichandani P, Pro MJ, Moster MR, Katz LJ, Hark LA, Myers JS. The Wills Eye Glaucoma App: Interest of Patients and Their Caregivers in a Smartphone-based and Tablet-based Glaucoma Application. J Glaucoma. 2016 Sep;25 — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patients Owning Smartphone/Tablet Technology	Responses collected from participants about owning access to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.	1 hour
Primary	Patients Having Access to Social Media Via Smartphone or Tablet in the Home	Responses collected from participants about their personal access, through other members in the home, to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.	1 hour
Secondary	Glaucoma Medication Compliance	Responses collected from participants about compliance to using their glaucoma drops as prescribed obtained by completing a 20 item questionnaire.	1 hour
Secondary	Use of Medication Reminder	Responses collected from participants about use of medication reminders for their glaucoma drops obtained by completing a 20 item questionnaire.	1 hour